Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis. - Wikidata - wikimedia - TriplyDB

Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis.

Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis.

http://www.wikidata.org/entity/Q33889328

about

Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis.

http://www.wikidata.org/entity/Q33889328

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@ast

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@en

type

label

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@ast

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@en

prefLabel

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@ast

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@en

P1433

Q33889328-0C4B2093-2DB6-46F0-8A2D-BD1273A15FA1

P1476

Q33889328-B76EFDF1-D231-47B2-9E3A-01CC69646D07

P2093

Q33889328-3D1780D6-ADC6-4FC8-9C10-43B2FF7BDE6A

Q33889328-3D82671B-28A9-4361-8112-19278FF838C5

Q33889328-B1EE7328-283C-4772-839A-E96B06FD1C25

Q33889328-B9F2E959-14FB-42DC-95A2-5538A92FABD5

Q33889328-CA9F17CE-D5E3-4E49-AF59-8D83855F7A3D

Q33889328-CFB84F83-8585-4652-8938-85ECAF3D2F52

P2860

Q33889328-00E9937D-A4E5-414E-BFED-5D357B62FB1C

Q33889328-0C1A23B4-1B5E-4960-8980-541FB112A0DC

Q33889328-116E818F-3438-4B74-A6AA-7A907CDED472

Q33889328-18101E44-794E-427F-A933-CCC26D73FE46

Q33889328-1E28A942-E92A-4E65-B0B5-37B799DB7802

Q33889328-2F44D193-32AE-48B3-8A6E-CA1692068915

Q33889328-4309459B-6CDF-4D8D-AB0C-F8B1292C1B00

Q33889328-467B8666-A475-4473-A973-A9368B67AA3B

Q33889328-4E2D9880-8DC5-4154-9568-4C899C604462

Q33889328-51E5DCB2-88C5-46EF-8B10-1FE895CAB525

P304

Q33889328-5BF25965-CBAA-465C-90C3-F085FCD2560D

P31

Q33889328-4A82FB31-429D-46A0-A395-0C2603424CCF

Q33889328-c5cb415d-c8c2-4cc7-9f7d-d33a5a4924f5

P356

Q33889328-882EB9B2-8154-458E-8F55-4A0125B38DDF

P407

Q33889328-53113010-FB6C-4A23-9BAC-DC37A1E1E4CF

P433

Q33889328-F31EE8D3-DB5C-4CAA-87AB-618E7417F245

P478

Q33889328-7AC5F956-36AE-4562-855B-5ABD4B900FBD

P577

Q33889328-FDBA6727-F58E-444F-AEC9-35241714CDAC

P698

Q33889328-389873D7-CF18-4F79-8F7F-4F1000BBD4D0

P932

Q33889328-116BA28A-E797-4269-8CC2-459FB3FB9FD1

P356

ONCOTARGET.17784

P1433

P1476

Efficacy and safety comparison ...... ncer: A network meta-analysis.

@en

P2093

Hongtao Hou

http://www.w3.org/2001/XMLSchema#string

Jinping Sun

http://www.w3.org/2001/XMLSchema#string

Ke Li

http://www.w3.org/2001/XMLSchema#string

Quanxing Ge

http://www.w3.org/2001/XMLSchema#string

Xinfang Sun

http://www.w3.org/2001/XMLSchema#string

Zheng Ren

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging role of S-1 in gastric cancer

S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysis

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

Gastric cancer: current and evolving treatment landscape

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction.

Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study.

P304

39673-39682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17784

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28562333

http://www.w3.org/2001/XMLSchema#string

P932

5503642

http://www.w3.org/2001/XMLSchema#string